Elanco Animal Health Q1 2024 10-Q Filing
Ticker: ELAN · Form: 10-Q · Filed: 2024-05-08T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Elanco Animal Health filed its Q1 2024 10-Q, detailing financial performance for the period ending March 31, 2024.
AI Summary
Elanco Animal Health Inc. reported its first quarter 2024 results, ending March 31, 2024. The company's financial performance for the quarter is detailed in this 10-Q filing, providing insights into its revenue, expenses, and overall financial health. Specific financial figures and operational details for the period are available within the document.
Why It Matters
This filing provides investors and analysts with the official financial performance data for Elanco Animal Health for the first quarter of 2024, crucial for evaluating the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing and does not inherently present new risks.
Key Players & Entities
- Elanco Animal Health Inc. (company) — Filer of the 10-Q
- March 31, 2024 (date) — End of the reporting period
- 20240508 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2024.
When was this 10-Q filed with the SEC?
This 10-Q filing was made on May 8, 2024.
What is Elanco Animal Health Inc.'s Central Index Key (CIK)?
Elanco Animal Health Inc.'s Central Index Key is 0001739104.
What is Elanco Animal Health Inc.'s fiscal year end?
Elanco Animal Health Inc.'s fiscal year ends on December 31.
What is the business address of Elanco Animal Health Inc.?
The business address is 2500 Innovation Way, Greenfield, IN 46140.
From the Filing
0001739104-24-000018.txt : 20240508 0001739104-24-000018.hdr.sgml : 20240508 20240508090659 ACCESSION NUMBER: 0001739104-24-000018 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240508 DATE AS OF CHANGE: 20240508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825497352 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 24924463 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 10-Q 1 elan-20240331.htm 10-Q FOR THE PERIOD ENDED MARCH 31, 2024 elan-20240331 false 2024 Q1 0001739104 --12-31 1 0001739104 2024-01-01 2024-03-31 0001739104 2024-05-03 xbrli:shares iso4217:USD 0001739104 2023-01-01 2023-03-31 iso4217:USD xbrli:shares 0001739104 2024-03-31 0001739104 2023-12-31 0001739104 us-gaap:CommonStockMember 2022-12-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001739104 us-gaap:RetainedEarningsMember 2022-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001739104 2022-12-31 0001739104 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001739104 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001739104 us-gaap:CommonStockMember 2023-03-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001739104 us-gaap:RetainedEarningsMember 2023-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001739104 2023-03-31 0001739104 us-gaap:CommonStockMember 2023-12-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001739104 us-gaap:RetainedEarningsMember 2023-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001739104 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001739104 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001739104 us-gaap:CommonStockMember 2024-03-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001739104 us-gaap:RetainedEarningsMember 2024-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001739104 us-gaap:RevolvingCreditFacilityMember 2024-01-01 2024-03-31 0001739104 us-gaap:Revol